Fosaprepitant 00591-4385
Product NDC
00591-4385- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 19, 2019
- Listing Expires
- December 31, 2026
- Application
- NDA210064
Need to source Fosaprepitant? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fosaprepitant Dimeglumine | 150 mg/1 |
Drug Class
Cytochrome P450 2C9 Inducers [MoA]Cytochrome P450 3A4 Inducers [MoA]Cytochrome P450 3A4 Inhibitors [MoA]
Packaging Options(1)
1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0591-4385-79)